Related Experiment Videos
Campylobacter pylori: Swedish experiences.
P Unge1, H Gnarpe, C Blomqvist
1Medical Dept., Sandviken Hospital, Sweden.
Scandinavian Journal of Gastroenterology. Supplement
|January 1, 1989
Summary
Serologic tests for Campylobacter pylori (C. pylori) show high accuracy for screening patients before gastroscopy. Current antibiotics and anti-ulcer drugs were ineffective in eradicating C. pylori infections.
Area of Science:
- Gastroenterology
- Microbiology
- Immunology
Background:
- Campylobacter pylori (C. pylori) is associated with duodenal and gastric ulcers.
- Accurate diagnostic methods for C. pylori are crucial for effective patient management.
Purpose of the Study:
- To evaluate the efficacy of serologic tests for C. pylori screening.
- To assess the correlation between C. pylori and ulcer presence.
- To investigate the effectiveness of various treatments for C. pylori eradication.
Main Methods:
- Patients undergoing gastroscopy were tested for C. pylori via culture and antibody titration.
- An enzyme immunoassay was developed and validated.
- Treatment trials included antibiotics (doxycycline, tinidazole, amoxycillin, norfloxacin) and anti-ulcer agents (enprostil, rioprostil, omeprazole).
Main Results:
- The developed enzyme immunoassay demonstrated a high negative predictive value (0.997) for C. pylori.
- A strong correlation was observed between active/inactive duodenal and gastric ulcers and positive C. pylori cultures.
- Antibiotics and anti-ulcer agents tested did not effectively eradicate C. pylori.
Conclusions:
- Serologic testing is a reliable method for screening C. pylori infections prior to gastroscopy.
- C. pylori is closely linked to the pathogenesis of duodenal and gastric ulcers.
- Current antibiotic and anti-ulcer therapies are ineffective against C. pylori.